Synexus India is off and running
After opening its doors in India in April, UK-based Synexus Clinical Research is off and running with its first two clinical trials in the region.
After opening its doors in India in April, UK-based Synexus Clinical Research is off and running with its first two clinical trials in the region.
New research show that the outsourcing trend is set to drive the analytical laboratory market over the next seven years, however small labs are in danger of drowning in the process.
GlaxoSmithKline (GSK) has formed a partnership with ChemoCentryx worth $1.5bn (€1.2bn) which will provide the company with access to selected targets from one of the broadest pipelines of chemokine-based therapeutics in the biotech industry.
Offshoring contract manufacturing is not the only option for large pharma firms looking to drive productivity and efficiency gains in drug manufacturing, warns a new report from independent market analyst Datamonitor.